2277 related articles for article (PubMed ID: 19455129)
1. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
2. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
3. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
4. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
[TBL] [Abstract][Full Text] [Related]
5. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
6. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
[TBL] [Abstract][Full Text] [Related]
7. DLG5 variants in inflammatory bowel disease.
Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
[TBL] [Abstract][Full Text] [Related]
8. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
[TBL] [Abstract][Full Text] [Related]
9. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
[TBL] [Abstract][Full Text] [Related]
10. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
[TBL] [Abstract][Full Text] [Related]
11. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
Vermeire S; Pierik M; Hlavaty T; Claessens G; van Schuerbeeck N; Joossens S; Ferrante M; Henckaerts L; Bueno de Mesquita M; Vlietinck R; Rutgeerts P
Gastroenterology; 2005 Dec; 129(6):1845-53. PubMed ID: 16344053
[TBL] [Abstract][Full Text] [Related]
12. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children.
Amre DK; Mack D; Israel D; Morgan K; Lambrette P; Law L; Grimard G; Deslandres C; Krupoves A; Bucionis V; Costea I; Bissonauth V; Feguery H; D'Souza S; Levy E; Seidman EG
Am J Gastroenterol; 2008 Mar; 103(3):615-20. PubMed ID: 18047539
[TBL] [Abstract][Full Text] [Related]
13. TUCAN (CARD8) genetic variants and inflammatory bowel disease.
McGovern DP; Butler H; Ahmad T; Paolucci M; van Heel DA; Negoro K; Hysi P; Ragoussis J; Travis SP; Cardon LR; Jewell DP
Gastroenterology; 2006 Oct; 131(4):1190-6. PubMed ID: 17030188
[TBL] [Abstract][Full Text] [Related]
14. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
15. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
[TBL] [Abstract][Full Text] [Related]
16. Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease.
van der Heide F; Nolte IM; Kleibeuker JH; Wijmenga C; Dijkstra G; Weersma RK
Am J Gastroenterol; 2010 May; 105(5):1165-72. PubMed ID: 19953089
[TBL] [Abstract][Full Text] [Related]
17. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
Noble CL; Nimmo ER; Drummond H; Ho GT; Tenesa A; Smith L; Anderson N; Arnott ID; Satsangi J
Gastroenterology; 2005 Dec; 129(6):1854-64. PubMed ID: 16344054
[TBL] [Abstract][Full Text] [Related]
18. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
[TBL] [Abstract][Full Text] [Related]
19. DLG5 variants contribute to Crohn disease risk in a Canadian population.
Newman WG; Gu X; Wintle RF; Liu X; van Oene M; Amos CI; Siminovitch KA
Hum Mutat; 2006 Apr; 27(4):353-8. PubMed ID: 16450402
[TBL] [Abstract][Full Text] [Related]
20. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease.
Tomer G; Ceballos C; Concepcion E; Benkov KJ
Am J Gastroenterol; 2003 Nov; 98(11):2479-84. PubMed ID: 14638352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
